These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22443536)

  • 21. Development of olmesartan medoxomil lipid-based nanoparticles and nanosuspension: preparation, characterization and comparative pharmacokinetic evaluation.
    B A; D N; Veerabrahma K
    Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):126-137. PubMed ID: 28290712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracellular trafficking of solid lipid nanoparticles and their distribution between cells through tunneling nanotubes.
    Kristl J; Plajnšek KT; Kreft ME; Janković B; Kocbek P
    Eur J Pharm Sci; 2013 Sep; 50(1):139-48. PubMed ID: 23628779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microwave-assisted formulation of solid lipid nanoparticles loaded with non-steroidal anti-inflammatory drugs.
    Shah RM; Eldridge DS; Palombo EA; Harding IH
    Int J Pharm; 2016 Dec; 515(1-2):543-554. PubMed ID: 27789371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery.
    Paliwal R; Rai S; Vaidya B; Khatri K; Goyal AK; Mishra N; Mehta A; Vyas SP
    Nanomedicine; 2009 Jun; 5(2):184-91. PubMed ID: 19095502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Techniques and Patents on Solid Lipid Nanoparticles as Novel Carrier for Drug Delivery.
    Khatak S; Dureja H
    Recent Pat Nanotechnol; 2015; 9(3):150-77. PubMed ID: 27009132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solid lipid nanoparticles for ocular drug delivery.
    Seyfoddin A; Shaw J; Al-Kassas R
    Drug Deliv; 2010; 17(7):467-89. PubMed ID: 20491540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral delivery of solid lipid nanoparticles: underlining the physicochemical characteristics and physiological condition affecting the lipolysis rate.
    Mahmoudian M; Maleki Dizaj S; Salatin S; Löbenberg R; Saadat M; Islambulchilar Z; Valizadeh H; Zakeri-Milani P
    Expert Opin Drug Deliv; 2021 Nov; 18(11):1707-1722. PubMed ID: 34553650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic-free nanotherapeutics: ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors.
    Nafee N; Husari A; Maurer CK; Lu C; de Rossi C; Steinbach A; Hartmann RW; Lehr CM; Schneider M
    J Control Release; 2014 Oct; 192():131-40. PubMed ID: 24997276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Solid Lipid Nanoparticle with Endosomal Escape Function for Oral Delivery of Insulin.
    Xu Y; Zheng Y; Wu L; Zhu X; Zhang Z; Huang Y
    ACS Appl Mater Interfaces; 2018 Mar; 10(11):9315-9324. PubMed ID: 29484890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and stability of nanostructured lipid carriers as drug delivery system.
    Abbasalipourkabir R; Salehzadeh A; Abdullah R
    Pak J Biol Sci; 2012 Feb; 15(3):141-6. PubMed ID: 22866544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
    Das S; Ng WK; Tan RB
    Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
    Song A; Zhang X; Li Y; Mao X; Han F
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solid Lipid Nanoparticles: A Promising Nanomaterial in Drug Delivery.
    Rajpoot K
    Curr Pharm Des; 2019; 25(37):3943-3959. PubMed ID: 31481000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
    Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
    Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: a review of the state of the art.
    Weber S; Zimmer A; Pardeike J
    Eur J Pharm Biopharm; 2014 Jan; 86(1):7-22. PubMed ID: 24007657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transport of stearic acid-based solid lipid nanoparticles (SLNs) into human epithelial cells.
    Shah RM; Rajasekaran D; Ludford-Menting M; Eldridge DS; Palombo EA; Harding IH
    Colloids Surf B Biointerfaces; 2016 Apr; 140():204-212. PubMed ID: 26764103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles.
    Li H; Zhao X; Ma Y; Zhai G; Li L; Lou H
    J Control Release; 2009 Feb; 133(3):238-44. PubMed ID: 18951932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intranasal delivery of nanoparticle encapsulated tarenflurbil: A potential brain targeting strategy for Alzheimer's disease.
    Muntimadugu E; Dhommati R; Jain A; Challa VG; Shaheen M; Khan W
    Eur J Pharm Sci; 2016 Sep; 92():224-34. PubMed ID: 27185298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Galactosylated solid lipid nanoparticles with cucurbitacin B improves the liver targetability.
    Wang W; Zhao X; Hu H; Chen D; Gu J; Deng Y; Sun J
    Drug Deliv; 2010 Apr; 17(3):114-22. PubMed ID: 20148709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sustained release of piroxicam from solid lipid nanoparticle as an effective anti-inflammatory therapeutics in vivo.
    Peng LH; Wei W; Shan YH; Chong YS; Yu L; Gao JQ
    Drug Dev Ind Pharm; 2017 Jan; 43(1):55-66. PubMed ID: 27498809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.